The University of Chicago Header Logo

Connection

Steffen Sammet to Administration, Oral

Back to Details
This is a "connection" page, showing publications Steffen Sammet has written about Administration, Oral.
Steffen Sammet
Connection Strength
0.020
Administration, Oral
  1. Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol. 2010 May 10; 28(14):2323-30.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.